Location: Home
  • search
  • go
  • Relate News
  • 1/20/2017NHFPC Announces the Outline of Key Health and Family Planning Tasks in...
  • 1/19/2017APR Licenses Greater China Rights of Patented Migraine Drug Formulatio...
  • 1/19/201715 Chinese Biopharma Cos Became Listed on the A Share Stock Market in ...
  • 1/19/2017Recent Executive Moves
  • 1/19/2017Ten Upcoming Trends of the Chinese Pharmaceutical Market in 2017
  • 1/19/2017The Outlook for China in the Global Pharmaceutical Market
  • 1/18/2017WuXi MedImmune Secures CFDA’s Clinical Approval for Phase I of RA Dru...
  • 1/17/2017Hangzhou Minsheng Takes Over Chinese Joint Venture with Sanofi
  • 1/17/2017Eight MNCs Submitted More Than 40 Chinese Drug Application in 2016
  • 1/17/2017Chi-Med Initiates a Phase II Study of Sulfatinib in Second-line Biliar...
  • 1/16/2017Mergermarket: Global Pharma and Biotech M&A Feels the Heat in 2016
  • 1/16/2017Inefficient Innovation in China
  • 1/16/2017China Issues New Document to Advance Disease Group-Based Fee Standards
  • 1/16/2017New NRDL Draft Issued to Local Governments for Feedbacks
  • 1/15/2017NHFPC Abolishes 68 Prior Policies and Notices
  • 1/13/2017CFDA Holds National Food and Drug Regulatory Conference, Outlining Reg...
  • 1/13/2017Chinese Healthcare / Biopharma M&A Reached A New Peak in 2016
  • 1/13/2017Data Snapshot - Urban Retail Pharmacy Consumption of Chemical Drugs 20...
  • 1/13/2017Data Snapshot - Overview of A-Share Listed Biopharma Companies 2016
  • 1/12/2017Recent Executive Moves
  • 1/12/2017China's Ingredient Industry Ponders Trump's Trade Stance
  • 1/12/2017State Council Issues the 13th Five-Year Plan on Health (2016-2020)
  • 1/12/2017L.E.K.: Winning in the Next Era - Strategies for the Changing Global ...
  • 1/11/2017CFDA Solicits Public Comments on Naming Principle of Formulated TCMs
  • 1/11/2017Demographic Convergence And The Coming Chinese Healthcare Explosion
  • 1/11/2017Chi-Med Initiates HMPL-523 Clinical Trials in Hematological Cancer in ...
  • 1/11/2017MilliporeSigma Expands Biodevelopment Centers to the U.S. and China
  • 1/10/2017State Council Issues China's 13th Five Year Plan for Healthcare Reform
  • 1/9/2017AbbVie, Genomics Medicine and WuXi NextCODE Announce Landmark Populati...
  • 1/9/2017Valeant To Sell Dendreon To Sanpower Group for $819.9M in Cash
  • Page:168/334 Total number of articles:10002: [First][<<] [166] [167] [168] [169] [170] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group